Human cathepsin F: Expression in baculovirus system, characterization and inhibition by protein inhibitors

Biological Chemistry

Volumn 385, Issue 6, 2004, Pages 505-509

  Fonovič, Marko ^a   Brömme, Dieter ^b   Turk, Vito ^a   Turk, Boris ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin; Cystatin; Cysteine protease; Thyropin

Indexed keywords

CATHEPSIN F; CYSTATIN; CYSTATIN C; KININOGEN; PEPSIN A; PROTEIN INHIBITOR; PROTEINASE; STEFIN A;

AMINO TERMINAL SEQUENCE; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; BINDING AFFINITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS;

ANIMALS; BACULOVIRIDAE; CATHEPSINS; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; HYDROLYSIS; KINETICS; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; SPODOPTERA;

GALLUS GALLUS; UNIDENTIFIED BACULOVIRUS;

EID: 3242745349     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.059     Document Type: Article

References (33)

1. Bevec, T., Stoka, V., Pungerčič, G., Dolenc, I., and Turk, V. (1996). Major histocompatibility complex class II associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183, 1331-1338.
2. Bocock, J.P., Edgell, C.J., Marr, H.S., and Erickson, A.H. (2003). Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. Eur. J. Biochem. 270, 4008-4015.
3. Brömme, D., Rinne, R., and Kirschke, H. (1991). Tight binding of cathepsin S by cystatins. Biomed. Biochim. Acta 50, 631-635.
4. Brömme, D., and Okamoto, K. (1995). The baculovirus cysteine protease has a cathepsin B-like S2-subsite specificity. Biol. Chem. 376, 611-615.
5. Brömme, D., Nallaseth, F.S., and Turk, B. (2004). Production and activation of recombinant papain-like cysteine proteases. Methods 32, 199-206.
6. Cereghino, G.P.L., Cereghino, J.L., Ilgen, C., and Cregg, J.M. (2002). Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr. Opin. Biotechnol. 13, 329-332.
7. Davies, A.H. (1995). Advances in the use of recombinant baculoviruses for the expression of heterologous proteins. Curr. Opin. Biotechnol. 6, 543-547.
8. Greco W.R., and Hakala, M.T. (1979). Evaluation of methods for estimating the dissociation constant of tight binding inhibitors. J. Biol. Chem. 254, 12104-12109.
9. Green, G.D.J., Kembhavi, A.A., Davies, M.E., and Barrett, A.J. (1984). Cystatin like proteinase inhibitors from human liver. Biochem. J. 218, 939-946.
10. Gunčar, G., Pungerčič, G., Klemenčič, I., Turk, V., and Turk, D. (1999). Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18, 793-803.
11. Ho, J.D., Meltser, Y., Buggy, J.J., Palmer, J.T., Elrod, K.C., Chan, H., Mortara, K.D., and Somoza, J.R. (2002). Expression, purification, crystallization and preliminary X-ray diffraction studies of human cathepsin F complexed with an irreversible vinyl sulfone inhibitor. Acta Cryst. D58, 2187-2190.
12. Lenarčič, B., Ritonja, A., Štrukelj, B., Turk, B., and Turk, V. (1997). Equistatin, a new inhibitor of cysteine proteinasesfrom Actinia equina, is structuraly related to thyroglobulin type-1 domain. J. Biol. Chem. 272, 13899-13903.
13. Lenarčič, B., and Bevec, T. (1998). Thyropins-new structuraly related proteinase inhibitors. Biol. Chem. 379, 105-111.
14. Leonardi, A., Turk, B., and Turk, V. (1996). Inhibition of bovine cathepsins L and S by stefins and cystatins. Biol. Chem. 377, 319-321.
15. Lindahl, P., Abrahamson, M., and Björk, I. (1992). Interaction of human cystatin C with the cysteine proteinases papain and actinidin. Biochem. J. 281, 49-55.
16. Morrison, J.F. (1982). The slow binding and slow, tight binding inhibition of enzyme catalysed reactions. Trends. Biochem. Sci. 7, 192-105.
17. Musil, D., Zucic, D., Turk, D., Engh, R.A., Mayr, I., Huber, R., Popovic, T., Turk, V., Towatari, T., and Katunuma, N. (1990). The refined 2.15 Å X-ray crystal structure of humen liver cathepsin B: the structural bases for its specificity. EMBO J. 10, 2321-2330.
18. Nägler, D.K., Sulea, T., and Ménard, R. (1999). Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. Biochem. Biophys. Res. Commun. 257, 313-318.
19. Pol, E., Olsson, S.L., Estrada, S., Prasthofer, T.W., and Björk, I. (1995). Characterisation by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases. Biochem. J. 311, 275-282.
20. Rossi, A., Deveraux, Q., Turk, B., and Sali, A. (2004). Comprehensive search for cysteine cathepsins in the human genome. Biol. Chem. 385, 363-372.
21. Salvesen, G., Parkes, C., Abrahamson, M., Grubb, A., and Barrett, A.J. (1986). Human low-Mr kininogen contains three copies of cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. Biochem. J. 234, 429-434.
22. Santamaria, I., Velasco, G., Pendas, A.M., Paz, A., and Lopez-Otin, C. (1999). Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J. Biol. Chem. 274, 13800-13809.
23. Shi, G.P., Bryant, R.A.R., Riese, R., Verhelst, S., Driessen, C., Li, Z., Brömme, D., Ploegh, H.L., and Chapman, H.A. (2000). Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191, 1177-1185.
24. Somoza, J.R., Palmer, J.T., and Ho, J.D. (2002). The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J. Mol. Biol. 322, 559-568.
25. Stoka, V., Lenarčič, B., Cazzulo, J.J., and Turk, V. (1999). Cathepsin S and cruzipain are inhibited by equistatin from Actinia equina. Biol. Chem. 380, 589-592.
26. Turk, B., Križaj, I., Kralj, B., Dolenc, I., Popovič, T., Bieth, J.G., and Turk, V. (1993). Bovine stefin C-a new member of the stefin family. J. Biol. Chem. 268, 7323-7329.
27. Turk, B., Ritonja, A., Björk, I., Stoka, V., Dolenc, I., and Turk, V. (1995). Identification of bovine stefin A, a novel protein inhibitor of cysteine proteinases. FEBS Lett. 360, 101-105.
28. Turk, B., Turk, V., and Turk, D. (1997). Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378, 141-150.
29. Turk, B., Turk, D., and Salvesen, G.S. (2002). Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Design 8, 1623-1637.
30. Turk, B., Turk, D., and Salvesen, G.S. (2004). Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Med. Chem. Reviews On-line, in press.
31. Vasiljeva, O., Dolinar, M., Turk, V., and Turk, B. (1993). Recombinant human cathepsin H lacking the minichain is an endopeptidases. Biochemistry 42, 13522-13528.
32. Wang, B., Shi, G.P., Yao, P.M., Li, Z., Chapman, H.A. and Brömme, D. (1998). Human cathepsin F. J. Biol. Chem. 273, 32000-32008.
33. Yamashita, M., and Konagaya, S. (1996). A novel cysteine protease inhibitor of the egg of chum salmon, containing a cysteine rich thyroglobulin-like motif. J. Biol. Chem. 271, 1282-1284.